Developer docs
API playgroundTry for free, no card

Search company profiles

Labex Canada

Full company profile

uuid002pe55

Namestring
Labex Canada
Legal namestring
Labex Canada Inc.
Websiteurl
labexcanada.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Labex Canada Inc. is a privately held Canadian medical equipment and in-vitro diagnostics company founded in 2011 and headquartered in Newmarket, Ontario. The company manufactures and globally distributes automated laboratory instruments and reagents used in cancer diagnostics, genetic testing, and pathological analysis. Its proprietary product portfolio includes two automated immunohistochemistry stainers (LC-AS20 with 20-slide capacity and LC-AS88 with 88-slide capacity), the LC-FH20 automatic FISH hybridizer, and the LC-DMS32 DNA methylation system. Labex also produces a catalog of over 116 IHC antibodies and approximately 500 FISH probes, 40 of which carry Health Canada certification for IHC antibodies and 3 for FISH probes.

The company operates a hybrid manufacturer-distributor business model. Beyond its own manufactured instruments and reagents, Labex serves as the exclusive global sales and marketing representative for Sycan Medtech (coagulation analyzers), Syscan Biotech (coagulation reagents), Long Island Antibodies Diagnostica (IHC/FISH products), and Beckman Coulter ELISA immunoassay kits in over 10 countries across South America, the Middle East, and Africa. Distribution is executed through a network of 25+ professional distributors across more than 20 countries, with Labex providing sales training and after-sales support. The company also offers Complete Laboratory Solutions, a turnkey modular laboratory setup platform introduced in 2016, and LCCP (Labex Complex Construction Project), a modular healthcare facility construction service launched in 2018.

Revenue is generated primarily through one-time hardware sales, recurring consumable sales tied to installed instruments, and project-based service fees for laboratory and healthcare facility solutions. The company manufactures COVID-19 diagnostic kits in its Ontario facility, which holds ISO 13485:2016 and MDSAP certifications. Labex has obtained Health Canada Medical Device Establishment Licence, CE/IVDR, and CE/IVDD certifications, enabling international market access. The company remains privately held with no disclosed institutional funding or revenue figures, and reports 1-10 employees.

Short descriptiontext

Labex Canada manufactures and globally distributes automated IHC stainers, FISH hybridizers, and DNA methylation systems, plus a catalog of IHC antibodies and FISH probes used by diagnostic laboratories for cancer and genetic testing, through a network of 25+ international distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNewmarket, Canada
HQ citystring
Newmarket
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical diagnostic equipment, in vitro diagnostics, immunohistochemistry stainers, FISH hybridization systems, DNA methylation analysis
Industry3 codes
PRIMARYHLAHAAAN
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)
SECONDARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
In Vitro Diagnostic (IVD) Medical Equipment and Reagents
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Medical and Laboratory Equipment Distribution
TypeOne Time License
Description

Import/export/marketing and distribution of products in the fields of medical and laboratory instrumentation, reagents, and test kits. Products are sold globally through distributor networks.

labexcanada.com
2IVD Products Sales
TypeHardware Sales
Description

Sale of IVD products including IHC stainers, FISH hybridizers, DNA methylation systems, antibodies, probes, and reagents. Revenue generated from instrument sales and consumables.

labexcanada.com
3COVID-19 Diagnostic Kits
TypeHardware Sales
Description

Manufacturing and sale of COVID-19 diagnostic products including RT-PCR kits, rapid antigen tests, and antibody tests. Kits manufactured in Ontario facility.

labexcanada.com
4Complete Laboratory Solutions
TypeManaged Services
Description

Offering complete turnkey laboratory solutions in different sizes, standards, and price points. Developed in 2016, this platform offers affordable laboratories sold successfully worldwide.

labexcanada.com
5LCCP (Labex Complex Construction Project)
TypeManaged Services
Description

Comprehensive range of various packages for the healthcare sector based on modular technology. Customers can choose from individual modules to complete projects including complex ones. Introduced in 2018.

labexcanada.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1LAVI Series
Description

Ventilation device with HFT function for intermittent pressure-controlled ventilation of patients, intended for invasive and non-invasive ventilation.

labexcanada.com
+2 more records
Core offering1 text field

Labex Canada manufactures and globally distributes automated in vitro diagnostic (IVD) laboratory instruments and reagents — including IHC stainers (LC-AS20, LC-AS88), FISH hybridizers (LC-FH20), DNA methylation systems (LC-DMS32), IHC antibodies, FISH probes, DNA methylation kits, and COVID-19 diagnostic kits. The company also designs, plans, and delivers turnkey laboratory and modular healthcare facility solutions (Complete Laboratory Solutions and LCCP).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 90% less labor required compared to manual processing with automated FISH Hybridizer
+3 more records
Product overview1 text field

Labex Canada is a medical equipment and IVD company operating as both a manufacturer and distributor. The company manufactures automated laboratory instruments including IHC Stainers (LC-AS20 with 20-slide capacity and LC-AS88 with 88-slide capacity), Automatic FISH Hybridizers (LC-FH20 with 20-slide capacity), and DNA Methylation Systems (LC-DMS32 with 32-sample capacity). In addition to instruments, Labex produces配套 reagents including IHC antibodies (40+ Health Canada certified), FISH probes (67+ products, 3 certified), and DNA methylation kits. The company also distributes Beckman Coulter Elisa kits across South America, Middle East, and Africa. Beyond products, Labex offers Complete Laboratory Solutions (modular laboratory setups) and LCCP (healthcare facility construction projects). All products come with full technical support and are tested in real laboratory conditions.

Product and service3 records
1Fully Automatic IHC Stainer LC-AS20
CategoryAutomated Laboratory Instrument
Description

Automated immunohistochemistry staining instrument with 20-slide capacity per run used by pathology and diagnostic laboratories for visualization of pathological conditions in tissues and cells.

2Fully Automatic IHC Stainer LC-AS88
CategoryAutomated Laboratory Instrument
Description

High-throughput automated immunohistochemistry stainer with 88-slide capacity per run featuring programmable operating software for flexible staining protocols, aimed at high-volume diagnostic laboratories.

3Automatic FISH Hybridizer LC-FH20
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Sycan Medtech
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2019-01-01
Description

Sycan Medtech is a manufacturer of fully automatic Coagulation Analyzers. In 2019, Labex Canada was appointed as Sales/Marketing department for the entire globe for Sycan Medtech products. This partnership provides Labex with automated coagulation diagnostic equipment for their product portfolio.

labexcanada.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2019-01-01
Description

Syscan Biotech is a manufacturer of a wide range of Coagulation reagents. In 2019, Labex Canada was appointed as Sales/Marketing department for the entire globe for Syscan Biotech products. This partnership complements the coagulation analyzer offerings.

3Long Island Antibodies Diagnostica
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2019-01-01
Description

Long Island Antibodies Diagnostica manufactures fully automatic immunohistochemistry (IHC) stainers, automatic FISH fluorescence in situ hybridization (FISH) hybridizers, and a wide range of primary and secondary antibodies and FISH probes. Appointed as global Sales/Marketing department in 2019.

labexcanada.com
4Beckman Coulter
Strategic tierCoreTypeTechnology or Integration
Description

Labex Canada is the exclusive sales office for over 10 countries in South America, the Middle East, and Africa for Beckman Coulter ELISA immunoassay kits. The portfolio covers reproductive problems (AMH, Inhibin A, Inhibin B, Free Testosterone), allergic conditions (Histamine), diabetes, and specialty topics (Vitamin D, Serotonin, Chromogranin A).

labexcanada.com
Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Sakura Finetek manufactures tissue processing, embedding, and automated IHC staining instrumentation, competing head-to-head with Labex's LC-AS20/LC-AS88 stainers in histology workflow automation.

TypeDirect peer
Description

BioGenex designs and manufactures automated IHC and FISH staining systems and reagent portfolios, overlapping directly with Labex's core IHC/FISH automation and reagent lines.

TypeBroad incumbent
Description

Roche's Ventana platform is the global leader in automated IHC and ISH staining and is the standard against which Labex's IHC and FISH systems must compete for hospital lab adoption.

TypeDirect peer
Description

Biocare Medical develops and manufactures IHC antibodies, FISH probes, and automated staining systems for cancer diagnostics - directly comparable product overlap with Labex's IHC/FISH portfolio and similar niche pathology focus.

TypeEmerging player
Description

Histo-Line produces histology and IHC equipment and reagents at smaller scale than incumbents, overlapping with Labex's specialty-automated instruments and emerging-market distribution model.

TypeEmerging player
Description

MEDITE supplies histology, cytology, and IHC workflow instruments and consumables for clinical labs, comparable in product breadth and target customer profile to Labex's Complete Laboratory Solutions offering.

TypeBroad incumbent
Description

Leica's BOND IHC/ISH stainers, primary antibodies, and FISH probes define the enterprise pathology standard Labex's LC-AS and FISH platforms must displace.

TypeBroad incumbent
Description

Dako/Agilent produces the benchmark IHC antibody catalog (HercepTest, ER/PR, etc.) that competes directly with Labex's 40+ Health Canada-certified antibodies and broader cancer panels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Labex Canada

In Vitro Diagnostic (IVD) Medical Equipment and Reagentslabexcanada.com

Labex Canada manufactures and globally distributes automated IHC stainers, FISH hybridizers, and DNA methylation systems, plus a catalog of IHC antibodies and FISH probes used by diagnostic laboratories for cancer and genetic testing, through a network of 25+ international distributors.

What Labex Canada does

Labex Canada Inc. is a privately held Canadian medical equipment and in-vitro diagnostics company founded in 2011 and headquartered in Newmarket, Ontario. The company manufactures and globally distributes automated laboratory instruments and reagents used in cancer diagnostics, genetic testing, and pathological analysis. Its proprietary product portfolio includes two automated immunohistochemistry stainers (LC-AS20 with 20-slide capacity and LC-AS88 with 88-slide capacity), the LC-FH20 automatic FISH hybridizer, and the LC-DMS32 DNA methylation system. Labex also produces a catalog of over 116 IHC antibodies and approximately 500 FISH probes, 40 of which carry Health Canada certification for IHC antibodies and 3 for FISH probes.

The company operates a hybrid manufacturer-distributor business model. Beyond its own manufactured instruments and reagents, Labex serves as the exclusive global sales and marketing representative for Sycan Medtech (coagulation analyzers), Syscan Biotech (coagulation reagents), Long Island Antibodies Diagnostica (IHC/FISH products), and Beckman Coulter ELISA immunoassay kits in over 10 countries across South America, the Middle East, and Africa. Distribution is executed through a network of 25+ professional distributors across more than 20 countries, with Labex providing sales training and after-sales support. The company also offers Complete Laboratory Solutions, a turnkey modular laboratory setup platform introduced in 2016, and LCCP (Labex Complex Construction Project), a modular healthcare facility construction service launched in 2018.

Revenue is generated primarily through one-time hardware sales, recurring consumable sales tied to installed instruments, and project-based service fees for laboratory and healthcare facility solutions. The company manufactures COVID-19 diagnostic kits in its Ontario facility, which holds ISO 13485:2016 and MDSAP certifications. Labex has obtained Health Canada Medical Device Establishment Licence, CE/IVDR, and CE/IVDD certifications, enabling international market access. The company remains privately held with no disclosed institutional funding or revenue figures, and reports 1-10 employees.

Labex Canada firmographics

Firmographics
Name
Labex Canada
Legal name
Labex Canada Inc.
Website
https://labexcanada.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1–10 employees
Short description
Labex Canada manufactures and globally distributes automated IHC stainers, FISH hybridizers, and DNA methylation systems, plus a catalog of IHC antibodies and FISH probes used by diagnostic laboratories for cancer and genetic testing, through a network of 25+ international distributors.
Ownership category
akta.pro rank

Labex Canada industry classification

Industry
Product category
In Vitro Diagnostic (IVD) Medical Equipment and Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHAAAN
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)
SECONDARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories

Keywords

  • Medical diagnostic equipment
  • In vitro diagnostics
  • Immunohistochemistry stainers
  • FISH hybridization systems
  • DNA methylation analysis

Where Labex Canada is headquartered

Location

Headquarters

HQ city
Newmarket
HQ country
Canada
HQ region
North America

Offices3 records

Markets served

Labex Canada business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical and Laboratory Equipment Distribution: Import/export/marketing and distribution of products in the fields of medical and laboratory instrumentation, reagents, and test kits. Products are sold globally through distributor networks.
  2. IVD Products Sales: Sale of IVD products including IHC stainers, FISH hybridizers, DNA methylation systems, antibodies, probes, and reagents. Revenue generated from instrument sales and consumables.
  3. COVID-19 Diagnostic Kits: Manufacturing and sale of COVID-19 diagnostic products including RT-PCR kits, rapid antigen tests, and antibody tests. Kits manufactured in Ontario facility.
  4. Complete Laboratory Solutions: Offering complete turnkey laboratory solutions in different sizes, standards, and price points. Developed in 2016, this platform offers affordable laboratories sold successfully worldwide.
  5. LCCP (Labex Complex Construction Project): Comprehensive range of various packages for the healthcare sector based on modular technology. Customers can choose from individual modules to complete projects including complex ones. Introduced in 2018.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Labex Canada product offering

Product offering

Core offering

Labex Canada manufactures and globally distributes automated in vitro diagnostic (IVD) laboratory instruments and reagents — including IHC stainers (LC-AS20, LC-AS88), FISH hybridizers (LC-FH20), DNA methylation systems (LC-DMS32), IHC antibodies, FISH probes, DNA methylation kits, and COVID-19 diagnostic kits. The company also designs, plans, and delivers turnkey laboratory and modular healthcare facility solutions (Complete Laboratory Solutions and LCCP).

Product overview

Labex Canada is a medical equipment and IVD company operating as both a manufacturer and distributor. The company manufactures automated laboratory instruments including IHC Stainers (LC-AS20 with 20-slide capacity and LC-AS88 with 88-slide capacity), Automatic FISH Hybridizers (LC-FH20 with 20-slide capacity), and DNA Methylation Systems (LC-DMS32 with 32-sample capacity). In addition to instruments, Labex produces配套 reagents including IHC antibodies (40+ Health Canada certified), FISH probes (67+ products, 3 certified), and DNA methylation kits. The company also distributes Beckman Coulter Elisa kits across South America, Middle East, and Africa. Beyond products, Labex offers Complete Laboratory Solutions (modular laboratory setups) and LCCP (healthcare facility construction projects). All products come with full technical support and are tested in real laboratory conditions.

Differentiator

Problem solved

Functional benefit

Brands

  • LAVI Series: Ventilation device with HFT function for intermittent pressure-controlled ventilation of patients, intended for invasive and non-invasive ventilation.
  • LCCP (Labex Complex Construction Project)
  • Complete Laboratory Solutions

Products and services

  • Fully Automatic IHC Stainer LC-AS20 Automated immunohistochemistry staining instrument with 20-slide capacity per run used by pathology and diagnostic laboratories for visualization of pathological conditions in tissues and cells.
  • Fully Automatic IHC Stainer LC-AS88 High-throughput automated immunohistochemistry stainer with 88-slide capacity per run featuring programmable operating software for flexible staining protocols, aimed at high-volume diagnostic laboratories.
  • Automatic FISH Hybridizer LC-FH20

Quantifiable outcome

  • 90% less labor required compared to manual processing with automated FISH Hybridizer
  • +3 more outcomes

Companies that use Labex Canada

Customer profile

Segments3 records

Ideal customer profiles3 records

Labex Canada technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Labex Canada partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Sycan MedtechcoreTechnology or Integration · 1 January 2019Sycan Medtech is a manufacturer of fully automatic Coagulation Analyzers. In 2019, Labex Canada was appointed as Sales/Marketing department for the entire globe for Sycan Medtech products. This partnership provides Labex with automated coagulation diagnostic equipment for their product portfolio.
  • Syscan BiotechcoreTechnology or Integration · 1 January 2019Syscan Biotech is a manufacturer of a wide range of Coagulation reagents. In 2019, Labex Canada was appointed as Sales/Marketing department for the entire globe for Syscan Biotech products. This partnership complements the coagulation analyzer offerings.
  • Long Island Antibodies DiagnosticacoreTechnology or Integration · 1 January 2019Long Island Antibodies Diagnostica manufactures fully automatic immunohistochemistry (IHC) stainers, automatic FISH fluorescence in situ hybridization (FISH) hybridizers, and a wide range of primary and secondary antibodies and FISH probes. Appointed as global Sales/Marketing department in 2019.
  • Beckman CoultercoreTechnology or IntegrationLabex Canada is the exclusive sales office for over 10 countries in South America, the Middle East, and Africa for Beckman Coulter ELISA immunoassay kits. The portfolio covers reproductive problems (AMH, Inhibin A, Inhibin B, Free Testosterone), allergic conditions (Histamine), diabetes, and specialty topics (Vitamin D, Serotonin, Chromogranin A).

Scale indicators9 records

Recent moves11 records

Expansion highlights5 records

Labex Canada competitors and assessment

Company assessment

Direct peers

  • Sakura Finetek: Sakura Finetek manufactures tissue processing, embedding, and automated IHC staining instrumentation, competing head-to-head with Labex's LC-AS20/LC-AS88 stainers in histology workflow automation.
  • BioGenex Laboratories: BioGenex designs and manufactures automated IHC and FISH staining systems and reagent portfolios, overlapping directly with Labex's core IHC/FISH automation and reagent lines.
  • Biocare Medical: Biocare Medical develops and manufactures IHC antibodies, FISH probes, and automated staining systems for cancer diagnostics - directly comparable product overlap with Labex's IHC/FISH portfolio and similar niche pathology focus.

Broad incumbents

  • Roche Diagnostics (Ventana): Roche's Ventana platform is the global leader in automated IHC and ISH staining and is the standard against which Labex's IHC and FISH systems must compete for hospital lab adoption.
  • Leica Biosystems (Danaher): Leica's BOND IHC/ISH stainers, primary antibodies, and FISH probes define the enterprise pathology standard Labex's LC-AS and FISH platforms must displace.
  • Dako (Agilent Technologies): Dako/Agilent produces the benchmark IHC antibody catalog (HercepTest, ER/PR, etc.) that competes directly with Labex's 40+ Health Canada-certified antibodies and broader cancer panels.

Emerging players

  • Histo-Line Laboratories: Histo-Line produces histology and IHC equipment and reagents at smaller scale than incumbents, overlapping with Labex's specialty-automated instruments and emerging-market distribution model.
  • MEDITE Medical GmbH: MEDITE supplies histology, cytology, and IHC workflow instruments and consumables for clinical labs, comparable in product breadth and target customer profile to Labex's Complete Laboratory Solutions offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Labex Canada social profiles

Digital presence

Labex Canada compliance and trust

Trust signal

Compliance10 records

Labex Canada financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Labex Canada leadership team

Management profile

Number of profiles

Profiles1 record

Labex Canada funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Labex Canada M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labex Canada

What does Labex Canada do?

Labex Canada manufactures and globally distributes automated in vitro diagnostic (IVD) laboratory instruments and reagents — including IHC stainers (LC-AS20, LC-AS88), FISH hybridizers (LC-FH20), DNA methylation systems (LC-DMS32), IHC antibodies, FISH probes, DNA methylation kits, and COVID-19 diagnostic kits. The company also designs, plans, and delivers turnkey laboratory and modular healthcare facility solutions (Complete Laboratory Solutions and LCCP).

Is Labex Canada a public or private company?

Labex Canada is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Labex Canada founded?

Labex Canada was founded in 2011. It employs 1 to 10 people.

Where is Labex Canada based?

Labex Canada is headquartered in Newmarket, Canada, in the North America region.

How does Labex Canada make money?

Five revenue lines are on record. Medical and Laboratory Equipment Distribution is the primary driver. The others are IVD Products Sales, COVID-19 Diagnostic Kits, complete Laboratory Solutions and LCCP (Labex Complex Construction Project).

Who are Labex Canada's main competitors?

Direct peers on record are Sakura Finetek, BioGenex Laboratories and Biocare Medical. Broad incumbents are Roche Diagnostics (Ventana), Leica Biosystems (Danaher) and Dako (Agilent Technologies). Emerging players are Histo-Line Laboratories and MEDITE Medical GmbH.

Does Labex Canada have an API?

No public API is recorded for Labex Canada.

What industry is Labex Canada in?

Labex Canada's product category is In Vitro Diagnostic (IVD) Medical Equipment and Reagents. Its primary akta.pro industry code is HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics), with a secondary code of HLAGAIAD, Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales